High dose atorvastatin therapy and QTc interval in patients treated with coronary bypass surgery

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1526-1528

  Kabir, Saboor ^a   Hjortshøj, Søren ^a   Schmidt, Erik Berg ^a   Arya, Arash ^b   Christensen, Jeppe Hagstrup ^a   Lundbye Christensen, Søren ^a   Riahi, Sam ^a,c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

Coronary artery bypass grafting; Electrocardiography; QTc interval; Statin

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ELECTROCARDIOGRAM; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HUMAN; HYPERLIPIDEMIA; LETTER; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

CORONARY ARTERY BYPASS GRAFTING; ELECTROCARDIOGRAPHY; QTC INTERVAL; STATIN;

AGED; CORONARY ARTERY BYPASS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; TREATMENT OUTCOME;

EID: 84885308906     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.11.008     Document Type: Article

References (9)

1. Cholesterol Treatment Trialists' (CTT) Collaboration. Lancet November 13 2010;376(Issue 9753):1670-81
2. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. Tekin A, Tekin G, Sezgin AT, Müderrisoǧlu H. Short-and long-term effect of simvastatin therapy on the heterogeneity of cardiac repolarization in diabetic patients. Pharmacol Res May 2008;57(5):393-7.
4. Riahi S, Schmidt EB, Amanavicius N, et al. The effect of atorvastatin on heart rate variability and lipoproteins in patients treatedwith coronary bypass surgery. Int J Cardiol 2006;111(3):436-41.
5. Mark L, Katona A. Effect of fluvastatin on QT dispersion: a new pleiotropic effect? Am J Cardiol 2000;85:919-20.
6. Szabo Z, HarangiM, Lorincz I, et al. Effects of hyperlipidemia on QT dispersion in patients with ischemic heart disease. Can J Cardiol 2005;21:847-50.
7. Vrtovec B, Stojanvic I, Radovancevic R, Yazdanbakhsh AP, Thomas CD, Radovancevic B. Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients. J Heart Lung Transplant 2006;25:234-6.
8. Vrtovec B, Okrajsek R, Golienik A, Ferjan M, Starc V, Randovancevic B. Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. J Card Fail 2005;11:684-90.
9. Gualdiero P, Esposito K, Ciotola M, et al. Simvastatin normalized QTc dispersion and reduced ventricular electrical instability in isolated hypercholesterolemia. J Endocrinol Invest 2002;25:RC16-8.